Long-term safety of subcutaneous C1-esterase inhibitor in the prophylactic treatment of hereditary angioedema

Category Primary study
JournalAllergy and Asthma Proceedings
Year 2019
This article has no abstract
Epistemonikos ID: f632eeba810ba0c8c33459cc55eaa586959b5a79
First added on: Feb 11, 2025